Inventor
SHAH KALPANA
US19 patents
Patents
19 patentsUS10577422B2Mar 3, 2020
PD-1-binding molecules and methods of use thereof
MACROGENICS INC19 citations94
US10160806B2Dec 25, 2018
Covalently bonded diabodies having immunoreactivity with PD-1 and LAG-3, and methods of use thereof
MACROGENICS INC18 citations94
US10647768B2May 12, 2020
Multi-chain polypeptide-containing tri-specific binding molecules
MACROGENICS INC19 citations92
US11623959B2Apr 11, 2023
PD-1-binding molecules and methods of use thereof
MACROGENICS INC6 citations84
US10633440B2Apr 28, 2020
Multi-chain polypeptide-containing tri-specific binding molecules that specifically bind to multiple cancer antigens
MACROGENICS INC11 citations84
US11858991B2Jan 2, 2024
LAG-3-binding molecules and methods of use thereof
MACROGENICS INC2 citations73
US11384149B2Jul 12, 2022
Bi-specific monovalent Fc diabodies that are capable of binding CD32B and CD79b and uses thereof
MACROGENICS INC4 citations73
US11098119B2Aug 24, 2021
Covalently bonded diabodies having immunoreactivity with PD-1 and LAG-3, and methods of use thereof
MACROGENICS INC2 citations73
US11072653B2Jul 27, 2021
LAG-3-binding molecules and methods of use thereof
MACROGENICS INC4 citations73
US10344092B2Jul 9, 2019
Bi-specific monovalent Fc diabodies that are capable of binding CD32B and CD79b and uses thereof
MACROGENICS INC5 citations73
US10954301B2Mar 23, 2021
Bispecific molecules having immunoreactivity with PD-1 and CTLA-4, and methods of use thereof
MACROGENICS INC3 citations72
US9932400B2Apr 3, 2018
Bi-specific monovalent diabodies that are capable of binding to gpA33 and CD3, and uses thereof
MACROGENICS INC2 citations72
US11820818B2Nov 21, 2023
Multi-chain polypeptide-containing tri-specific binding molecules
MACROGENICS INC1 citations71
US11697684B2Jul 11, 2023
Tri-specific binding molecules that specifically bind to multiple cancer antigens
MACROGENICS INC1 citations71
US10501552B2Dec 10, 2019
Multivalent molecules comprising DR5-binding domains
MACROGENICS INC6 citations71
US11840571B2Dec 12, 2023
Methods of using bispecific molecules having immunoreactivity with PD-1 and CTLA-4
MACROGENICS INC0 citations62
US12534531B2Jan 27, 2026
PD-1-binding molecules and methods of use thereof
MACROGENICS INC0 citations61
US12435155B2Oct 7, 2025
CD137 binding molecules and uses thereof
MACROGENICS INC0 citations59
US10858430B2Dec 8, 2020
Bi-specific monovalent diabodies that are capable of binding to gpA33 and CD3, and uses thereof
MACROGENICS INC0 citations51